A molecular mechanism for transthyretin amyloidogenesis
A number of disease-causing human transthyretin (TTR) mutations are known to lead to amyloid formation. Here the authors combine neutron crystallography, native mass spectrometry and modelling studies to characterize the T119M and S52P-TTR mutants, providing mechanistic insights into TTR amyloidosis...
Enregistré dans:
Auteurs principaux: | Ai Woon Yee, Matteo Aldeghi, Matthew P. Blakeley, Andreas Ostermann, Philippe J. Mas, Martine Moulin, Daniele de Sanctis, Matthew W. Bowler, Christoph Mueller-Dieckmann, Edward P. Mitchell, Michael Haertlein, Bert L. de Groot, Elisabetta Boeri Erba, V. Trevor Forsyth |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d3204d9671444e838d043f4321cfd3bb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
par: Ricardo Sant'Anna, et autres
Publié: (2016) -
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel
par: Guglielmo Verona, et autres
Publié: (2017) -
Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
par: J Gustav Smith, et autres
Publié: (2021) -
Aggregated transthyretin is specifically packaged into placental nano-vesicles in preeclampsia
par: Mancy Tong, et autres
Publié: (2017) -
Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina
par: Maria S. Saez, et autres
Publié: (2021)